Kaitlin Meade, M.S., LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 110 N 11th St, Seneca, KS 66538 Phone: 785-336-2173 |
News Archive
"Midlife adults entered adulthood at a time of more widespread use of complementary and alternative medicine (CAM) in the population and when public health policy was shifting attention toward individual responsibility for health and health promotion," said Joseph G. Grzywacz, Ph.D., and his colleagues, writing in the October issue of the Journal of Aging and Health.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced it submitted a supplemental New Drug Application with the U.S. Food and Drug Administration (FDA) for a Ready-to-Use formulation of FUSILEV (levoleucovorin) for Injection.
Laboratory Corporation of America Holdings announced today the immediate availability of an enhanced version of its HCV GenoSure NS3/4, a drug resistance test that screens for the Q80K polymorphism. Q80K is a naturally occurring polymorphism that develops in certain strains of HCV, making the virus less susceptible to Janssen Therapeutics' OLYSIO (simeprevir), which was recently approved by the U.S. Food and Drug Administration for the treatment of certain adult patients diagnosed with genotype 1chronic hepatitis C.
Congenica, a global provider of clinical genomics interpretation software, today announced a new customer partnership with the Coimbra Paediatric Hospital, a leading paediatric hospital in Portugal and part of the Coimbra Hospital and University Centre.
› Verified 8 days ago